Phase 3 study of avelumab in combination with axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Motzer, R. J.; Choueiri, T.; Larkin, J.; Albiges, L.; Haanen, J. B.; Schmidinger, M.; Atkins, M. B.; Mariani, M.; Shnaidman, M.; Di Pietro, A.; Rini, B. I. |
| Abstract Title: | Phase 3 study of avelumab in combination with axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi293 |
| Language: | English |
| ACCESSION: | WOS:000393912500839 |
| DOI: | 10.1093/annonc/mdw373.71 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 844TiP -- Source: Wos |
